Macrophage migration inhibitory factor: A regulator of glucocorticoid activity with a critical role in inflammatory disease

Molecular Medicine Today

Volumn 3, Issue 11, 1997, Pages 502-507

  Donnelly, Seamas C ^a   Bucala, Richard ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MACROPHAGE MIGRATION INHIBITION FACTOR;

ACUTE PHASE RESPONSE; ADULT RESPIRATORY DISTRESS SYNDROME; DRUG RESISTANCE; HORMONE ACTION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; NONHUMAN; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SEPSIS; STEROID THERAPY;

ANIMALS; ENDOTOXEMIA; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; PITUITARY GLAND, ANTERIOR; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0030694048     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01133-7     Document Type: Review

References (29)

1. Goldstein, R.A., Dowen, D.L. and Fauci, A.S. (1992) Adrenal corticosteroids, in Inflammation: Basic Principles and Clinical Correlates, 2nd edn (Gallin, J.I., Goldstein, I.M. and Snyderman, R., eds), pp. 1061-1081, Raven Press
2. Bloom, B.R. and Bennett, B. (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity, Science 153, 80-82
3. David, J. (1966) Delayed hypersensitivity in vitro: its mediation by cell free substances formed by lymphoid cell-antigen interaction, Proc. Natl. Acad. Sci. U. S. A. 56, 72-77
4. Calandra, T. et al. (1995) MIF as a glucocorticoid-induced modulator of cytokine production, Nature 377, 68-71
5. Bemhagen, J. et al. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia, Nature 365, 756-759
6. Nishino, T. et al. (1995) Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland, Mol. Med, 1, 781-788
7. Calandra, T., Bemhagen, J., Mitchell, R.A. and Bucala, R. (1994) The macrophage is an important and previously unrecognised source of macrophage migration inhibitory factor,J. Exp. Med. 179, 1895-1902
8. Bemhagen, J. et al. (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF), Biochemistry 33, 14144-14155
9. Bemhagen, J. et al. (1996) An essential role for macrophage migration inhibitory factor (MIF) in the tuberculin delayed-type hypersensitivity reaction, J. Exp. Med. 183, 277-282
10. Bacher, M. et al. (1997) Migration inhibitory factor expression in experimentally induced endotoxemia, Am. J. Pathol 150, 235-246
11. Lan, H.Y. et al (1996) De novo renal expression of macrophage migration inhibitory factor during the development of rat crescenteric glomerulo-nephritis, Am. J. Pathol. 149, 1119-1127
12. Lan, H.Y. et al (1997) The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat, J. Exp. Med. 185, 1455-1465
13. Mikulowska, A. et al (1997) Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice, J.Immunol. 158, 5514-5517
14. Bacher, M. et al. (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation, Proc. Natl. Acad. Sci. U. S. A. 93, 7849-7854
15. Beutler, B. et al. (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance, Science 270, 977-980
16. Scheinman, R.I., k Cogswell, P.C., Lofquist, A.K. and Baldwin, A.S. (1995) Role of transcriptional activation of IκBκ in mediation of immunosuppression of gluco-corticoids, Science 270, 283-290
17. Auphan, N. et al. (1995) Immunosuppression by glucocorticoids: inhibition of NF-κb activity through induction of IkB synthesis, Science 270, 286-290
18. Sun, H.W., Bemhagen, J., Bucala, R. and Lolis, E. (1996) Crystal structure at 2.6-Å resolution of human macrophage migration inhibitory factor, Proc. Natl. Acad. Sci. U. S. A. 93, 5191-5196
19. Suzuki, M. et al (1996) Crystal structure of the macrophage migration inhibitory factor from rat liver, Nat. Struct. Biol. 3, 259-266
20. Subramanya, H.S. et al. (1996) Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases, Biochemistry 35, 792-802
21. Rosengren, E. et al. (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction, Mol. Med. 2, 143-149
22. Donnelly, S.C. et al. (1997) Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome, Nat. Med. 3, 320-323
23. Donnelly, S.C. et al. (1994) Role of selectins in development of adult respiratory distress syndrome, Lancet 344, 215-219
24. Donnelly, S.C. et al. (1993) Interleukin 8 (IL-8) and the development of the adult respiratory distress syndrome (ARDS) in at-risk patient groups, Lancet 1341, 643-647
25. Donnelly, S.C. and Haslett, C. (1992) Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome, Thorax 47, 260-263
26. Barnes, P.J., Greening, A.P. and Crompton, G.K. (1995) Glucocorticoid resistance in asthma, Am. J. Respir. Crit. Care Med. 152, S125-S142
27. Adcock, I.M. et al. (1995) Abnormal glucocorticoid receptor-activator protein-1 interaction in steroid resistant asthma, J. Exp. Med. 182, 1951-1958
28. Adcock, I.M. and Barnes, P.J. (1995) Steroid resistant asthma, Q. J. Med. 88, 455-568
29. Martin, T.R. (1997) Cytokines and the acute respiratory distress syndrome (ARDS): a question of balance, Nat. Med. 3, 272-273